Just in
HealthSTAT+: Enforcement of stringent Medicaid work requirements delayed for six months
Enforcement of the Trump administration's stringent new Medicaid work requirements have been delayed for six months, until July 1, 2027.
STAT
Everything on the wire from STAT (US).
STAT+: Democrats coalesce around ‘Medicare for More,’ ‘Medikids’ proposals
Democrats are coalescing around a plan to offer Medicare to more Americans, if not all of them.
New addiction society guidance on medetomidine’s brutal withdrawal
The American Society of Addiction Medicine has released the first national guidance for recognizing and treating patients who have taken medetomidine.
STAT+: Doctors have questions about the Watchman. Boston Scientific has a sales pitch.
The Boston Globe investigates if Boston Scientific's marketing of its cardiac implant, Watchman, outpaced the science.
STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
STAT+: HHS plans funding for research into ibogaine for PTSD
The Trump administration will funnel up to $4.9 million into supporting research into ibogaine, a psychedelic that’s drawn interest as a potential treatment for PTSD and addiction.
Opinion: New organ donation rules are unfair to families
New organ donation rules may “blur the line between the physicians fighting to save a patient's life and the teams responsible for organ procurement.”
Brain implant startup pauses trials
Synchron has paused clinical trials of its second-generation brain-computer interface. Leaders say the pause is not safety related.
STAT+: Pharmalittle: We’re reading about Lilly conflict questions, a DEA OK for a narcolepsy pill, and more
A deal for smart-ring maker Oura to acquire a telehealth company is raising conflict-of-interest questions for Eli Lilly
STAT+: Senators introduce bill to curb conflicts of interest on preventive care panel
Some of the panel's members could benefit financially from the decisions they make, STAT's reporting showed.
The future of heart drug research in the wake of study setbacks
What does the failure of two closely watched heart disease medicines mean for the future of drug research in the field? Find out on this week's episode of "The Readout…
Senator-elect Abdul El-Sayed on restoring trust in science, the state of public health, and RFK Jr.
Senator-elect Abdul El-Sayed talks to STAT about restoring trust in science, the state of public health, and RFK Jr.
STAT+: Oura’s acquisition of health tech startup raises conflict-of-interest questions for Eli Lilly, experts say
With a new deal announced this week, the relationship between Eli Lilly and a telehealth company that markets GLP-1s is expected to grow more complicated.
5 takeaways from STAT’s investigation of the sprawling ‘three-parent IVF’ industry
A STAT investigation of the fertility tourism industry found that clinics are offering an unproven IVF procedure to older women. Here are 5 takeaways from the investigation.
Opinion: STAT+: ‘What will I do with the time I have left?’: What it’s like to find out you might develop Alzheimer’s
“What people fear isn’t the end of life, the demise of the animated body, but the demise of the mind,” writes Jason Karlawish.
Across the U.S., homegrown experiments aim to save kids from their phones
As researchers struggle to understand phone addiction, young people are finding ways to reclaim their attention and push back against Big Tech.
STAT+: Blackstone backs Pfizer’s bet on monthly obesity treatment
Pfizer spent up to $10 billion to buy Metsera last year. Now, it’s bringing in private equity behemoth Blackstone to help pay for the deal.
STAT+: Scientists debut map of basal ganglia, a key brain region involved in an array of diseases
A massive scientific collaboration has produced the most detailed map yet of the basal ganglia, a key brain region involved in an array of psychiatric and neurologic disorders.
STAT+: Will Heidi Overton get to run the FDA?
Does Heidi Overton have the votes ? And how will Dems take on RFK Jr.?
STAT+: New documents raise more questions about Medicare’s AI prior-authorization experiment
In this edition of STAT Health Tech: Oura's big bet on AI, a 'rumble strip' for clinical chatbots, and questions around Medicare’s AI prior-auth experiment.